DoH releases primary care guidelines for vaccine blood clots The Department of Health document outlines possible presentations, symptoms and signs to look out for, as well as initial investigations.
NSW Health provides rapid COVID testing for KFP candidates in Sydney The RACGP and NSW Health worked to ensure the exam can be held amid current restrictions in the state.
Could a routine blood test improve dementia outcomes? Researchers are hoping a simple blood protein point-of-care test will aid early detection of cognitive impairment.
DoH confirms vaccine indemnity scheme, but questions remain ‘You shouldn’t fear that you’re going to get tied up in complicated litigation if something – despite your best efforts – goes wrong,’ the DoH First Assistant Secretary has told GPs.
National Cabinet announces no-fault indemnity scheme for GPs to administer AstraZeneca The move opens the door for under-60s to receive the vaccine as the country looks to speed up the rollout amid a potential national outbreak.
New AstraZeneca guidance reinforces need for vaccine counselling MBS numbers The decision to limit the use of AstraZeneca’s COVID vaccine to only people aged 60 and older will likely place more pressure on GPs dealing with vaccine-hesitant patients.
History of blood clots not usually a reason to avoid AstraZeneca Patients who have had blood clots or take blood thinners often ask these two haematologists, ‘Should I have the AstraZeneca vaccine?’
New saliva test has potential to detect COVID-19 in five minutes It’s considered a next generation approach to testing and could further assist in minimising the risks of viral spread.
Identifying and treating vaccine-linked blood clots in general practice Other than age, there are ‘no known risk factors’ associated with developing blood clots with low platelets following an AstraZeneca vaccination, but GPs can still take steps to protect patients.
Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.